Works matching IS 10233830 AND DT 2009 AND VI 58 AND IP 4

Results: 8

Inhibitory effect of ZPDC glycoprotein on the expression of inflammation-related cytokines through p38 MAP kinase and JNK in lipopolysaccharide-stimulated RAW 264.7 cells.
Published in:
Inflammation Research, 2009, v. 58, n. 4, p. 184, doi. 10.1007/s00011-008-8118-2
By:
- S.-J. Lee;
- K.-T. Lim
Publication type:
Article
Induction of muscle weakness by local inflammation: an experimental animal model.
Published in:
Inflammation Research, 2009, v. 58, n. 4, p. 175, doi. 10.1007/s00011-008-8093-7
By:
- S. Bicer;
- P. Reiser;
- S. Ching;
- N. Quan
Publication type:
Article
Concentrations of α- and β-defensins in plasma of patients with inflammatory bowel disease.
Published in:
Inflammation Research, 2009, v. 58, n. 4, p. 192, doi. 10.1007/s00011-008-8120-8
By:
- N. Yamaguchi;
- H. Isomoto;
- H. Mukae;
- H. Ishimoto;
- K. Ohnita;
- S. Shikuwa;
- Y. Mizuta;
- M. Nakazato;
- S. Kohno
Publication type:
Article
3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti- Saccharomyces cerevisiae antibodies and ileal location of Crohn’s disease in Tunisian population.
Published in:
Inflammation Research, 2009, v. 58, n. 4, p. 218, doi. 10.1007/s00011-008-8139-x
By:
- R. Marrakchi;
- K. Bougatef;
- A. Moussa;
- S. Ouerhani;
- H. Khodjet-el-Khil;
- Y. Messai;
- O. Mestiri;
- T. Najar;
- A. Benammar-Elgaaeid
Publication type:
Article
A new model of outbred genetically selected mice which present a strong acute inflammatory response in the absence of complement component C5.
Published in:
Inflammation Research, 2009, v. 58, n. 4, p. 204, doi. 10.1007/s00011-008-8132-4
By:
- M. Amano;
- A. Carneiro;
- O. Ribeiro;
- W. Cabrera;
- M. De Franco;
- O. Ibañez;
- L. Isaac;
- N. Starobinas
Publication type:
Article
Suramin inhibits macrophage activation by human group IIA phospholipase A2, but does not affect bactericidal activity of the enzyme.
Published in:
Inflammation Research, 2009, v. 58, n. 4, p. 210
By:
- E. Aragão;
- L. Chioato;
- T. Ferreira;
- A. de Medeiros;
- A. Secatto;
- L. Faccioli;
- R. Ward
Publication type:
Article
Enhancement of activated β1-integrin expression by prostaglandin E2 via EP receptors in isolated human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease.
Published in:
Inflammation Research, 2009, v. 58, n. 4, p. 224, doi. 10.1007/s00011-008-8138-y
By:
- M. Kajimoto;
- T. Ichiyama;
- Y. Ueno;
- M. Shiraishi;
- M. Hasegawa;
- S. Furukawa
Publication type:
Article
Neutrophil elastase inhibitor (sivelestat) reduces the Levels of inflammatory mediators by inhibiting NF-kB.
Published in:
Inflammation Research, 2009, v. 58, n. 4, p. 198, doi. 10.1007/s00011-008-8131-5
By:
- S. Hagiwara;
- H. Iwasaka;
- S. Hidaka;
- A. Hasegawa;
- T. Noguchi
Publication type:
Article

Works matching IS 10233830 AND DT 2009 AND VI 58 AND IP 4

Inhibitory effect of ZPDC glycoprotein on the expression of inflammation-related cytokines through p38 MAP kinase and JNK in lipopolysaccharide-stimulated RAW 264.7 cells.

Induction of muscle weakness by local inflammation: an experimental animal model.

Concentrations of α- and β-defensins in plasma of patients with inflammatory bowel disease.

3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti- Saccharomyces cerevisiae antibodies and ileal location of Crohn’s disease in Tunisian population.

A new model of outbred genetically selected mice which present a strong acute inflammatory response in the absence of complement component C5.

Suramin inhibits macrophage activation by human group IIA phospholipase A<sub>2</sub>, but does not affect bactericidal activity of the enzyme.

Enhancement of activated β<sub>1</sub>-integrin expression by prostaglandin E<sub>2</sub> via EP receptors in isolated human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease.

Neutrophil elastase inhibitor (sivelestat) reduces the Levels of inflammatory mediators by inhibiting NF-kB.